Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.6%

5 terminated out of 47 trials

Success Rate

81.5%

-5.0% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed with results

Key Signals

6 with results81% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (9)
Early P 1 (2)
P 1 (4)
P 2 (8)
P 3 (4)

Trial Status

Completed22
Unknown6
Recruiting5
Terminated5
Withdrawn3
Enrolling By Invitation2

Trial Success Rate

81.5%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (47)

Showing 20 of 20 trials
NCT07291960Not Yet Recruiting

Retinal Clinical Assessment With AI-derived Quantitative Information

NCT04704921Phase 2Active Not RecruitingPrimary

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT01432847Recruiting

Cell Collection to Study Eye Diseases

NCT05407636Phase 3RecruitingPrimary

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

NCT07269769Phase 3Not Yet RecruitingPrimary

A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

NCT07424235Completed

Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort

NCT04796545Not ApplicableRecruitingPrimary

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

NCT07375901Not ApplicableCompletedPrimary

the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

NCT05547633RecruitingPrimary

Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients With Exudative AMD (SINE)

NCT03845582Phase 2Completed

Phase 2/3 Study of ALK-001 in Geographic Atrophy

NCT07216677Active Not Recruiting

A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases

NCT03803631CompletedPrimary

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

NCT05210803Enrolling By Invitation

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

NCT03478865Early Phase 1CompletedPrimary

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

NCT01766596Not ApplicableCompletedPrimary

Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort)

NCT04739319Recruiting

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

NCT04078672Not ApplicableCompletedPrimary

Retinal Imaging Using NOTAL-OCT V3.0

NCT03843840CompletedPrimary

Dual Wavelength OCT

NCT02348359Phase 2Terminated

X-82 to Treat Age-related Macular Degeneration

NCT05056025Not ApplicableUnknownPrimary

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

Scroll to load more

Research Network

Activity Timeline